Cargando…

Corrigendum: MELD-XI Score Is Associated With Short-Term Adverse Events in Patients With Heart Failure With Preserved Ejection

Detalles Bibliográficos
Autores principales:	Wang, Sunying, Wang, Yuwei, Luo, Manqing, Lin, Kaiyang, Xie, Xiaoxu, Lin, Na, Yang, Qingyong, Zou, Tian, Chen, Xinan, Xie, Xianwei, Guo, Yansong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268323/ https://www.ncbi.nlm.nih.gov/pubmed/34250053 http://dx.doi.org/10.3389/fcvm.2021.717166

Ejemplares similares

MELD-XI Score Is Associated With Short-Term Adverse Events in Patients With Heart Failure With Preserved Ejection
por: Wang, Sunying, et al.
Publicado: (2021)

The MELD-XI score predicts 3-year mortality in patients with chronic heart failure
por: Lin, Zebin, et al.
Publicado: (2022)

Hepatic dysfunction and adverse outcomes after total arch repair of acute type a aortic dissection: application of the MELD-XI score
por: Lin, Xinfan, et al.
Publicado: (2022)

Corrigendum: Cost-effectiveness of adding empagliflozin to the standard therapy for Heart Failure with Preserved Ejection Fraction from the perspective of healthcare systems in China
por: Jiang, Yaohui, et al.
Publicado: (2023)

A Comparison Between Two Definitions of Contrast-Associated Acute Kidney Injury for Long-Term Mortality in Elderly and Non-elderly Patients After Elective Percutaneous Coronary Intervention
por: He, Haoming, et al.
Publicado: (2021)

Resting Cardiac Power Predicts Adverse Outcome in Heart Failure Patients With Preserved Ejection Fraction: A Prospective Study
por: Wang, Shiqi, et al.
Publicado: (2022)

Prognostic value of the MELD‐XI score in patients undergoing cardiac resynchronization therapy
por: Saito, Yuki, et al.
Publicado: (2022)

Prognostic relevance of left atrial function and stiffness in heart failure with preserved ejection fraction patients with and without diabetes mellitus
por: Zhu, Shuangshuang, et al.
Publicado: (2022)

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction
por: Zeng, Heng, et al.
Publicado: (2019)

Cost-effectiveness of adding empagliflozin to the standard therapy for Heart Failure with Preserved Ejection Fraction from the perspective of healthcare systems in China
por: Jiang, Yaohui, et al.
Publicado: (2022)

A Novel Three-Dimensional and Tissue Doppler Echocardiographic Index for Diagnosing and Prognosticating Heart Failure With Preserved Ejection Fraction
por: Wang, Weiding, et al.
Publicado: (2022)

Estimated Glomerular Filtration Rate Is Associated With an Increased Risk of Death in Heart Failure Patients With Preserved Ejection Fraction
por: Chen, Zhuo, et al.
Publicado: (2021)

Interatrial Shunt Device for Heart Failure With Preserved Ejection Fraction
por: Kaye, David M., et al.
Publicado: (2019)

Rationale for the Use of Pirfenidone in Heart Failure With Preserved Ejection Fraction
por: Graziani, Francesca, et al.
Publicado: (2021)

D-Dimer Is Associated With Coronary Microvascular Dysfunction in Patients With Non-obstructive Coronary Artery Disease and Preserved Ejection Fraction
por: Lin, Yan, et al.
Publicado: (2022)

The prognostic value of MELD-XI in elderly patients with ST-segment elevation myocardial infarction: an observational study
por: He, Song-jian, et al.
Publicado: (2021)

Weight Change and Mortality Risk in Heart Failure With Preserved Ejection Fraction
por: Huang, Peisen, et al.
Publicado: (2021)

Association Between Arterial Stiffness and Heart Failure With Preserved Ejection Fraction
por: Chi, Chen, et al.
Publicado: (2021)

Diving Into the Diagnostic Score Algorithms of Heart Failure With Preserved Ejection Fraction
por: Abramov, Dmitry, et al.
Publicado: (2021)

Heart failure with preserved ejection fraction—Out with the old and out with the new?
por: Tolento Cortes, Luis, et al.
Publicado: (2022)

Skeletal muscle phenotypic switching in heart failure with preserved ejection fraction
por: Saw, Eng Leng, et al.
Publicado: (2022)

Sympathetic and hemodynamic responses to exercise in heart failure with preserved ejection fraction
por: Manabe, Kazumasa, et al.
Publicado: (2023)

Inflammation as a therapeutic target in heart failure with preserved ejection fraction
por: Peh, Zhen Hui, et al.
Publicado: (2023)

Liver Dysfunction Assessed by Model for End-Stage Liver Disease Excluding INR (MELD-XI) Scoring System Predicts Adverse Prognosis in Heart Failure
por: Abe, Satoshi, et al.
Publicado: (2014)

Distinct features of calcium handling and β‐adrenergic sensitivity in heart failure with preserved versus reduced ejection fraction
por: Kilfoil, Peter J., et al.
Publicado: (2020)

Alteration of m6A RNA Methylation in Heart Failure With Preserved Ejection Fraction
por: Zhang, Beijian, et al.
Publicado: (2021)

Initial Invasive or Conservative Strategy in Heart Failure With Preserved Ejection Fraction and Coronary Artery Disease
por: Gu, Jun, et al.
Publicado: (2022)

Effects of rhythm control on left atrial structure remodeling in atrial fibrillation and heart failure with preserved ejection fraction
por: Bai, Lin, et al.
Publicado: (2023)

The Potential Therapeutic Role of Celastrol in Patients With Heart Failure With Preserved Ejection Fraction
por: Ajmal, Maryam, et al.
Publicado: (2021)

Gut Microbiota in Heart Failure Patients With Preserved Ejection Fraction (GUMPTION Study)
por: Huang, Ziyin, et al.
Publicado: (2022)

Association of Body-Weight Fluctuation With Outcomes in Heart Failure With Preserved Ejection Fraction
por: Li, Yi, et al.
Publicado: (2021)

Advances in Multimodality Cardiovascular Imaging in the Diagnosis of Heart Failure With Preserved Ejection Fraction
por: Del Torto, Alberico, et al.
Publicado: (2022)

Proteomic and phosphoproteomic profiling in heart failure with preserved ejection fraction (HFpEF)
por: Valero-Muñoz, María, et al.
Publicado: (2022)

C-reactive protein and statins in heart failure with reduced and preserved ejection fraction
por: Park, Jin Joo, et al.
Publicado: (2022)

Association between urine pH and risk of contrast-associated acute kidney injury among patients after emergency percutaneous coronary intervention: a V-shape relationship?
por: Chen, Hanchuan, et al.
Publicado: (2021)

Effect of Sodium-Glucose Cotransporter 2 Inhibitors for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Zhou, Hufang, et al.
Publicado: (2022)

Clinical Implications of Plasma Galectin-3 in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis
por: Shi, Yujiao, et al.
Publicado: (2022)

Heart Failure With Preserved Ejection Fraction and Adipose Tissue: A Story of Two Tales
por: Oh, Albin, et al.
Publicado: (2019)

Central and Obstructive Apneas in Heart Failure With Reduced, Mid-Range and Preserved Ejection Fraction
por: Borrelli, Chiara, et al.
Publicado: (2019)

Predictive Value of HFA-PEFF Score in Patients With Heart Failure With Preserved Ejection Fraction
por: Sun, Yuxi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6veafsq394m52nrrood42cru95